The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. We will continue to add to the board of Academic Editors and are seeking qualified and diverse academics who share our vision.
1981-1985. Graduate Student, MRC Laboratory of Molecular Biology, Cambridge, U.K.
1985-1989. Postdoctoral Fellow Department of Biochemistry, University of California, Berkeley, CA.
1989-2000. Assistant and Associate Professor, Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT.
2000- Staff Scientist, Genomics Division, Lawrence Berkeley National Laboratory, Berkeley CA.
Group Leader at The Francis Crick Institute from April 2015. Programme Leader and Wellcome Trust Career Development Fellow at National Institute for Medical Research in London, UK from end of 2008. Previously, Royal Society Dorothy Hodgkin Fellow at King’s College London.
Deputy Head of Genomics Department at Naval Medical Research Center, Biological Defense Research Directorate; Adjunct Assistant Professor of Emerging Infectious Diseases at Uniformed Services University of the Health Sciences; Henry M. Jackson Foundation contractor
Professor of Developmental Biology in the Laboratory of Molecular Biology, Department of Plant Sciences, Wageningen University, The Netherlands.
I am a neuropsychiatrist who also completed a movement disorders fellowship at Washington University. My research is primarily focused on neuroimaging and dopamine, especially in people with Tourette syndrome and Parkinson disease. I have also developed methods for structural imaging volumetry, analysis of brain images in nonhuman species, pharmacological fMRI (phMRI), and statistical analysis of anatomy-function relationships in deep brain stimulation (DBS).
Research director, leader of the team "RhoGTPases in osteoclast biology" at CNRS in Montpellier, France. Genreal secretary of the French Society for Cell Biology SBCF.
Max Planck Research Group Leader since 2014; assistant professor at Radboud University Nijmegen; PostDocs at University of Leuven and University of Strasbourg; PhD in Biophysics from Ludwig Maximilian University Munich; Research interests: mechanobiology, molecular force sensors, protein engineering, single molecule techniques (force and fluorescence); Editor of Biophysical Reviews and Letters
My primary research field is mammalian epigenetic control. My interests lie in using screens to identify novel epigenetic modifiers or new roles for known epigenetic modifiers, in order that we can expand our understanding of the molecular basis of epigenetic control. We study X chromosome inactivation in differentiating ES cells and early embryos, haematopoietic stem cells, neural stem cells and additionally study the role of the epigenetic modifier Smchd1 in the muscular dystrophy FSHD.
2011-:Schools of Cellular & Molecular Medicine and Biochemistry, University of Bristol: Reader in Microbiology.
2007-2011: as above, Senior Lecturer in Microbiology.
2001-2007: Dunn School of Pathology, University of Oxford: Guy Newton Senior Research Fellow.
1997-2000: Institute Pasteur, Paris: Postdoctoral fellow.
1996: EMBL, Heidelberg: Postdoctoral fellow.
1991-1995: EMBL, Heidelberg: PhD in Cell Biology
1988-1991: University College, London: B. Sc. in Genetics, 1st class.
Melanie Blokesch holds a PhD degree from the Ludwig-Maximilians-Universität in Munich, Germany. After a postdoctoral stay at Stanford University (USA; Department of Microbiology and Immunology) from 2005-2009 she joined the Swiss Federal Institute of Technology Lausanne (EPFL) in Lausanne, Switzerland as a tenure-track assistant professor in 2009.
A.W. and Mary Margaret Clausen Distinguished Professor; Director, Hormone Research Institute; and Executive Vice Chancellor and Provost. Serves on the Science Translational Medicine advisory board and founding Director, Immune Tolerance Network. A recipient of a Guggenheim Fellowship and elected member of the Academy of Arts and Sciences. Dr. Bluestone has spent over 30 years working as an immunologist interested in immune tolerance as it relates to autoimmunity and organ transplantation.
2013- Senior Lecturer, University of Manchester, Manchester, UK
2006-13 Lecturer, University of Manchester, Manchester, UK
2001-06 Junior Group Leader Max-Planck Institute of Immunobiology in Freiburg, Germany
2000-01 Postdoctoral Fellow, Max-Planck Institute of Immunobiology in Freiburg, Germany
1996 PhD, University of Genova, Italy and Institute of Molecular Pathology, Vienna, Austria
1989 Degree in Biological Sciences, University of Genoa, Italy